Physician profile
Trinity Belgrave
NPI 1730863481
$639.42
in general payments reported to CMS, 2019-2025
16 companies · $429 in 2025
The $429 reported for 2025 was more than what 76% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $13.83 · 2024: $196 · 2025: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $639.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $639.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $116.38 | 2025 | Titan Sgs Bailout Chuck |
| Novo Nordisk INC | $100.71 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Sanofi-Aventis U.S. LLC | $49.64 | 2024 | |
| Merck Sharp & Dohme LLC | $45.90 | 2025 | Enflonsia, Vaxneuvance, Capvaxive |
| Novartis Pharmaceuticals Corporation | $45.34 | 2024-2025 | |
| Cvrx, INC. | $44.68 | 2025 | Barostim Neo System |
| Exact Sciences Corporation | $34.40 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Phathom Pharmaceuticals, INC. | $32.89 | 2024 | Voquezna |
| Vertex Pharmaceuticals Incorporated | $30.61 | 2025 | |
| Abbvie INC. | $28.01 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $24.78 | 2024 | |
| Glaxosmithkline, LLC. | $22.88 | 2025 | Shingrix, Arexvy, Penmenvy |
| Alexion Pharmaceuticals, INC. | $21.35 | 2024 | Strensiq |
| Philips North America LLC | $14.75 | 2024 | (Ck7) Extended Holter |
| Kci USA, INC. | $13.83 | 2023 | Prevena, V.A.C.Instill |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $13.27 | 2024 | Terlivaz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trinity Belgrave listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.